13F Data
Security · CUSIP 53220KAD0

LIGAND PHARMACEUTICALS INC

NOTE 0.750 8/1 · institutional ownership from 13F filings
Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019Q1 2019Q4 2018Q3 2018Q1 2018Q4 2017Q3 2017Q2 2017
13F holders
1
Shares held
0
Value held
$0
New / sold out
0 / 0
Added / reduced
0 / 0
net – shares

13F holders by quarter

Q3 2015: 1Q4 2015: 1Q1 2016: 1Q2 2016: 1Q3 2016: 1Q4 2016: 1Q1 2017: 2Q2 2017: 2Q3 2017: 2Q4 2017: 1Q1 2018: 0Q3 2018: 1Q4 2018: 1Q1 2019: 1Q2 2019: 1Q3 2019: 2Q4 2019: 1Q1 2020: 1Q2 2020: 0
Q3 2015Q2 2020

Net shares bought by existing holders

Q3 2015: 250.0KQ4 2015: 0Q1 2016: 0Q2 2016: 0Q3 2016: 0Q4 2016: 0Q1 2017: 6.5MQ2 2017: -6.4MQ3 2017: -35.7KQ4 2017: -56.9KQ1 2018: -250.0KQ3 2018: 0Q4 2018: 0Q1 2019: 0Q2 2019: 0Q3 2019: 39Q4 2019: 0Q1 2020: 0Q2 2020: 0
Q3 2015Q2 2020

Top holders · Q3 2018

ManagerSharesValue% of portfolio
PROEQUITIES, INC.0$00.00%

Biggest buyers

Nothing to show.

Biggest sellers

Nothing to show.